Kyverna Therapeutics, Inc. (KYTX)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | 8-K (2026-05-12) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-26) · 99.1 | 8-K (2026-01-12) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-12) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-12) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-13) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-03-27) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-13) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-12) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-14) · 99.1 | ||
| 10-K | 8-K (2024-03-26) |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Balance Sheets | ||
| Balance Sheets (P) | ||
| Condensed Statements of Operations and Comprehensive Income (loss) | — |
|
| Statements of Operations and Comprehensive Loss | ||
| Condensed Statements of Stockholders' Equity (deficit) | — |
|
| Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (deficit) | ||
| Statements of Cash Flows | ||
| Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (deficit) (P) | ||
| Statements of Cash Flows (P) | ||
| Notes | ||
| Available-for-sale Marketable Securities | ||
| Award Timing Disclosure | — |
|
| Balance Sheet Components | ||
| Commitments and Contingent Liabilities | ||
| Common Stock | ||
| Cybersecurity Risk Management, Strategy and Governance | — |
|
| Description of Business, Organization and Liquidity | ||
| Equity Incentive Plans | ||
| Fair Value Measurements and Fair Value of Financial Instruments | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| License and Collaboration Agreements | ||
| Net Loss Per Share Attributable To Common Stockholders | ||
| Pay Vs Performance Disclosure | ||
| Property and Equipment, Net | — |
|
| Redeemable Convertible Preferred Stock | ||
| Related Party Transactions | ||
| Segment Reporting | ||
| Significant Agreements | — |
|
| Stockholders' Equity | — |
|
| Subsequent Events | — |
|
| Summary of Significant Accounting Policies | ||
| Term Loan | ||